Cargando…

Adherence to dietary treatment and clinical factors associated with anti-transglutaminase antibodies in celiac disease during the follow-up

INTRODUCTION: In clinical practice, celiac disease (CD) is monitored through anti-transglutaminase (TGA-IgA) antibody levels. The normalization of serum levels in successive periodic measurements indicates good response and adherence to dietary treatment. OBJECTIVES: To evaluate the factors associat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miró, Marta, Alonso-Garrido, Manuel, Lozano, Manuel, Peiró, Juanjo, Manyes, Lara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047491/ https://www.ncbi.nlm.nih.gov/pubmed/33889773 http://dx.doi.org/10.1016/j.heliyon.2021.e06642

Ejemplares similares

Circulating anti-hypothalamus antibodies in celiac patients: tissue transglutaminase friend or foe?
por: Iervasi, Erika, et al.
Publicado: (2023)

Clinical Value of Tissue Transglutaminase Antibodies in Celiac Patients over a Long Term Follow-Up
por: Farina, Elisa, et al.
Publicado: (2021)

Injection of prototypic celiac anti-transglutaminase 2 antibodies in mice does not cause enteropathy
por: Lindstad, Christian B., et al.
Publicado: (2022)

Intestinal Production of Anti-Tissue Transglutaminase 2 Antibodies in Patients with Diagnosis Other Than Celiac Disease
por: Maglio, Mariantonia, et al.
Publicado: (2017)

The Production of the Oral Mucosa of Antiendomysial and Anti—Tissue-Transglutaminase Antibodies in Patients with Celiac Disease: A Review
por: Compilato, Domenico, et al.
Publicado: (2010)

Association of Anti-tissue Transglutaminase Antibody Titers and Duodenal Biopsy Findings in Pediatric Patients of Celiac Disease
por: Taneja, Kanchan, et al.
Publicado: (2021)

The Role of Pumpkin Pulp Extract Carotenoids Against Mycotoxin Damage in The Blood Brain Barrier in Vitro
por: Alonso-Garrido, Manuel, et al.
Publicado: (2021)

Tissue Transglutaminase but Not Microbial Transglutaminase Is Inhibited by Exogenous Oxidative Substances in Celiac Disease
por: Stricker, Sebastian, et al.
Publicado: (2022)

B cell tolerance and antibody production to the celiac disease autoantigen transglutaminase 2
por: du Pré, M. Fleur, et al.
Publicado: (2019)

Antibody Responses to Transglutaminase 3 in Dermatitis Herpetiformis: Lessons from Celiac Disease
por: Kaunisto, Helka, et al.
Publicado: (2022)

Celiac Anti-Type 2 Transglutaminase Antibodies Induce Phosphoproteome Modification in Intestinal Epithelial Caco-2 Cells
por: Paolella, Gaetana, et al.
Publicado: (2013)

Mucosal tissue transglutaminase expression in celiac disease
por: Villanacci, Vincenzo, et al.
Publicado: (2009)

Variability of anti-human transglutaminase testing in celiac disease across Mediterranean countries
por: Smarrazzo, Andrea, et al.
Publicado: (2017)

Association of Tissue Transglutaminase Antibody Titer with Duodenal Histological Changes in Children with Celiac Disease
por: Hawamdeh, Hasan, et al.
Publicado: (2016)

Tissue Transglutaminase Antibody and Its Association with Duodenal Biopsy in Diagnosis of Pediatric Celiac Disease
por: Meena, Daleep K., et al.
Publicado: (2019)

Relationship of citrulline and tissue transglutaminase antibody with duodenal histopathology among children with celiac disease()
por: Rahmani, Parisa, et al.
Publicado: (2022)

The importance of anti-transglutaminase IgA antibody detection in the diagnosis of celiac disease – case report of an inappropriate diagnostic approach
por: Szymańska, Edyta, et al.
Publicado: (2015)

Clinical characteristics of COVID-19 hospitalized patients associated with mortality: A cohort study in Spain
por: Lozano, Manuel, et al.
Publicado: (2022)

Intestinal Anti-tissue Transglutaminase2 Autoantibodies: Pathogenic and Clinical Implications for Celiac Disease
por: Maglio, Mariantonia, et al.
Publicado: (2020)

Erratum to “Association of Tissue Transglutaminase Antibody Titer with Duodenal Histological Changes in Children with Celiac Disease”
por: Hawamdeh, Hasan, et al.
Publicado: (2019)

Anti Transglutaminase Antibodies Cause Ataxia in Mice
por: Boscolo, Sabrina, et al.
Publicado: (2010)

Specificity of Tissue Transglutaminase Explains Cereal Toxicity in Celiac Disease
por: Vader, L. Willemijn, et al.
Publicado: (2002)

Microbial Transglutaminase Is Immunogenic and Potentially Pathogenic in Pediatric Celiac Disease
por: Torsten, Matthias, et al.
Publicado: (2018)

Microbial transglutaminase should be considered as an environmental inducer of celiac disease
por: Lerner, Aaron, et al.
Publicado: (2019)

Comparison of Clinical, Biochemical and Histological Features between Adult Celiac Patients with High and Low Anti-Transglutaminase IgA Titer at Diagnosis and Follow-Up
por: Galli, Gloria, et al.
Publicado: (2023)

Role of anti-tissue transglutaminase IgA+IgG antibodies in detection of potential celiac disease in patients with type 1 diabetes
por: Kaur, Navchetan, et al.
Publicado: (2019)

Interplay between Type 2 Transglutaminase (TG2), Gliadin Peptide 31-43 and Anti-TG2 Antibodies in Celiac Disease
por: Martucciello, Stefania, et al.
Publicado: (2020)

Celiac disease in patients with type-1 diabetes mellitus screened by tissue transglutaminase antibodies in northwest of Iran
por: Sharifi, Nasrin, et al.
Publicado: (2008)

Celiac Disease Dietary Adherence on the Rural–Urban Continuum
por: Posterick, Amy, et al.
Publicado: (2023)

Transcriptional Changes after Enniatins A, A1, B and B1 Ingestion in Rat Stomach, Liver, Kidney and Lower Intestine
por: Cimbalo, Alessandra, et al.
Publicado: (2021)

Effect of helicobacter pylori infection eradication on serum level of anti-tissue transglutaminase in children with celiac disease
por: Rohani, Pejman, et al.
Publicado: (2023)

Celiac disease can be predicted by high levels of tissue transglutaminase antibodies in children and adolescents with type 1 diabetes
por: Cerqueiro Bybrant, Mara, et al.
Publicado: (2020)

Can a Synbiotic Supplementation Contribute to Decreasing Anti-Tissue Transglutaminase Levels in Children with Potential Celiac Disease?
por: Demiroren, Kaan
Publicado: (2020)

HLA DQ2/DQ8 haplotypes and anti-transglutaminase antibodies as celiac disease markers in a pediatric population with type 1 diabetes mellitus
por: Oliveira, Diana Rita, et al.
Publicado: (2022)

Identification of celiac disease associated IgA nephropathy by IgA anti-tissue transglutaminase2 antibody deposits in archived formalin-fixed tissues
por: Dutta, Rimlee, et al.
Publicado: (2022)

Celiac Dietary Adherence Test and Standardized Dietician Evaluation in Assessment of Adherence to a Gluten-Free Diet in Patients with Celiac Disease
por: Gładyś, Katarzyna, et al.
Publicado: (2020)

Structural Basis for Antigen Recognition by Transglutaminase 2-specific Autoantibodies in Celiac Disease
por: Chen, Xi, et al.
Publicado: (2015)

Self-reported dietary adherence, disease-specific symptoms, and quality of life are associated with healthcare provider follow-up in celiac disease
por: Hughey, Jacob J., et al.
Publicado: (2017)

Anti-Transglutaminase 6 Antibodies in Children and Young Adults with Cerebral Palsy
por: Stenberg, Reidun, et al.
Publicado: (2014)

Anti-ganglioside antibodies and celiac disease
por: Granito, Alessandro, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nn7uhgj68u91b8pdu83k02rjcp